Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry corresponds to a sequestosome 1 (SQSTM1) pseudogene, a genomic DNA region similar in sequence to the protein-coding SQSTM1 gene but presumed to be non-functional for protein production. Pseudogenes such as this are not translated into functional proteins, and while certain pseudogenes have regulatory effects on gene expression or may be transcriptionally active, there is no evidence that this specific pseudogene encodes a therapeutic target or functional protein. Pseudogenes can occasionally influence their parental gene's regulation (for instance, as competing endogenous RNAs or through sequence exchange), but these effects are documented on a gene-by-gene basis and are not demonstrated for this entity[2][5][4]. The SQSTM1 gene codes for a multifunctional protein involved in autophagy, ubiquitin signaling, and various disease mechanisms, but pseudogenes like ENSG00000276586 lack these functional roles[3]. Pseudogenes are not classified as receptors, enzymes, or other protein-based therapeutic targets. Some pseudogenes may be transcribed and under certain circumstances serve as regulatory RNAs or disease biomarkers, but this is a general property and not specific to ENSG00000276586[2][5]. The term "Sequestosome 1 pseudogene" should not be used synonymously with the functional SQSTM1 gene or its protein product. This entry is not an established therapeutic target and should generally be excluded from lists of protein-coding, druggable targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sequestosome 1 pseudogene.